Literature DB >> 26807404

Induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa.

Stavros Spiliopoulos1, Nikolaos Davanos1.   

Abstract

Entities:  

Year:  2015        PMID： 26807404      PMCID： PMC4701520          DOI： 10.3978/j.issn.2305-5839.2015.09.42

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  12 in total

1.  The clinical spectrum of dystrophic epidermolysis bullosa.

Authors:  H M Horn; M J Tidman
Journal:  Br J Dermatol       Date:  2002-02       Impact factor: 9.302

2.  Formation of embryoid bodies from human pluripotent stem cells using AggreWell™ plates.

Authors:  Jennifer Antonchuk
Journal:  Methods Mol Biol       Date:  2013

3.  Fluoroscopically guided dilation of esophageal strictures in patients with dystrophic epidermolysis bullosa: long-term results.

Authors:  Stavros Spiliopoulos; Tarun Sabharwal; Miltiadis Krokidis; Panagiotis Gkoutzios; Jemima Mellerio; Renato Dourado; Andreas Adam
Journal:  AJR Am J Roentgenol       Date:  2012-07       Impact factor: 3.959

4.  Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice.

Authors:  Yingping Hou; Lin T Guey; Timothy Wu; Robert Gao; Jon Cogan; Xinyi Wang; Elizabeth Hong; Weihuang Vivian Ning; Douglas Keene; Nan Liu; Yan Huang; Craig Kaftan; Bruce Tangarone; Igor Quinones-Garcia; Jouni Uitto; Omar L Francone; David T Woodley; Mei Chen
Journal:  J Invest Dermatol       Date:  2015-07-23       Impact factor: 8.551

5.  Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.

Authors:  David T Woodley; Douglas R Keene; Tom Atha; Yi Huang; Kathi Lipman; Wei Li; Mei Chen
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

6.  Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells.

Authors:  Christian M Metallo; Lin Ji; Juan J de Pablo; Sean P Palecek
Journal:  Stem Cells       Date:  2007-10-25       Impact factor: 6.277

Review 7.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application.

Authors:  Gaoyang Liang; Yi Zhang
Journal:  Cell Stem Cell       Date:  2013-08-01       Impact factor: 24.633

8.  Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

Authors:  Fulvio Mavilio; Graziella Pellegrini; Stefano Ferrari; Francesca Di Nunzio; Enzo Di Iorio; Alessandra Recchia; Giulietta Maruggi; Giuliana Ferrari; Elena Provasi; Chiara Bonini; Sergio Capurro; Andrea Conti; Cristina Magnoni; Alberto Giannetti; Michele De Luca
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

Review 9.  Dystrophic epidermolysis bullosa: a review.

Authors:  Satoru Shinkuma
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-26

10.  Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Vittorio Sebastiano; Hanson Hui Zhen; Bahareh Haddad; Bahareh Haddad Derafshi; Elizaveta Bashkirova; Sandra P Melo; Pei Wang; Thomas L Leung; Zurab Siprashvili; Andrea Tichy; Jiang Li; Mohammed Ameen; John Hawkins; Susie Lee; Lingjie Li; Aaron Schwertschkow; Gerhard Bauer; Leszek Lisowski; Mark A Kay; Seung K Kim; Alfred T Lane; Marius Wernig; Anthony E Oro
Journal:  Sci Transl Med       Date:  2014-11-26       Impact factor: 19.319
View more
  1 in total

Review 1.  Current and Future Perspectives of Stem Cell Therapy in Dermatology.

Authors:  Christine M Prodinger; Julia Reichelt; Johann W Bauer; Martin Laimer
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.